Literature DB >> 3537006

Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum.

E J Bottone, M Reitano, J M Janda, K Troy, J Cuttner.   

Abstract

Ecthyma gangrenosum has not been described during the course of blood stream invasion with Pseudomonas maltophilia, although it occurs with a 30% frequency in Pseudomonas aeruginosa septicemia. We isolated P. maltophilia from the blood and an ecthyma lesion in a leukemic patient. The organism was an avid protease and elastase producer and hence mimicked the exoenzyme profile of invasive P. aeruginosa. The patient responded to moxalactam to which the isolate was susceptible in vitro. On the basis of this report, P. maltophilia may be included among an emerging number of gram-negative bacillary species capable of producing severe cutaneous manifestations of bacteremia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537006      PMCID: PMC269086          DOI: 10.1128/jcm.24.6.995-997.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Pseudomonas septicemia; observations on twenty-three cases.

Authors:  C E FORKNER; E FREI; J H EDGCOMB; J P UTZ
Journal:  Am J Med       Date:  1958-12       Impact factor: 4.965

2.  The role of the elastase of Pseudomonas aeruginosa in experimental infection.

Authors:  J D Mull; W S Callahan
Journal:  Exp Mol Pathol       Date:  1965-12       Impact factor: 3.362

3.  Pseudomonas maltophilia infections in man.

Authors:  G L Gilardi
Journal:  Am J Clin Pathol       Date:  1969-01       Impact factor: 2.493

Review 4.  Cutaneous and soft-tissue manifestations of sepsis due to gram-negative enteric bacilli.

Authors:  D M Musher
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

5.  Pseudomonas septicemia. Illustrated evolution of its skin lesion.

Authors:  G J Dorff; N F Geimer; D R Rosenthal; M W Rytel
Journal:  Arch Intern Med       Date:  1971-10

6.  Pseudomonas cepacia endocarditis and ecthyma gangrenosum.

Authors:  I N Mandell; H D Feiner; N M Price; M Simberkoff
Journal:  Arch Dermatol       Date:  1977-02

7.  Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature.

Authors:  J J Zuravleff; V L Yu
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

8.  Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.

Authors:  A I McKevitt; D E Woods
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

9.  Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool.

Authors:  J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

  9 in total
  6 in total

1.  Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates.

Authors:  Renjan Thomas; Rukman Awang Hamat; Vasanthakumari Neela
Journal:  Virulence       Date:  2014-01-21       Impact factor: 5.882

2.  Bacteremia and subcutaneous abscess caused by Proteus penneri in a neutropenic host.

Authors:  H D Engler; K Troy; E J Bottone
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 3.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 4.  Antimicrobial therapy for Stenotrophomonas maltophilia infections.

Authors:  A C Nicodemo; J I Garcia Paez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-04       Impact factor: 3.267

5.  Characterization of putative pathogenic Shewanella algae isolated from ballast water.

Authors:  Nik Nuraznida Nik Ibrahim; Nurathirah Mat Nasir; Fathul Karim Sahrani; Asmat Ahmad; Fareed Sairi
Journal:  Vet World       Date:  2021-03-19

Review 6.  The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis.

Authors:  Sofie Depluverez; Simon Devos; Bart Devreese
Journal:  Front Microbiol       Date:  2016-08-30       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.